-

Northwell Nurse Sandra Lindsay is First for Pfizer COVID Vaccine – Again

NEW HYDE PARK, N.Y.--(BUSINESS WIRE)--The first American to receive the COVID-19 vaccine in 2020 repeated the feat again today as part of a public health awareness event. Sandra Lindsay, RN, became a global phenomenon on December 14, 2020, when the Northwell Health critical care nurse director received the Pfizer-BioNTech COVID-19 vaccine.

Nearly three years later, Nurse Lindsay volunteered to be the first American to receive this season’s shot: Pfizer-BioNTech 2023-24 COVID-19 vaccine. This mRNA formulation offers protection against BA.2, BA.2.86 “Pirola,” EG.5 “Eris,” XBB.1.5 COVID variants – needed immunity as COVID hospitalizations begin to rise ahead of the fall and winter season.

Despite serving on the front lines of the pandemic, Nurse Lindsay has yet to be infected with COVID-19. “It’s important that people understand that COVID is still around and can still severely affect an individual,” said Nurse Lindsay. “Having worked through the darkest days of the pandemic and seen the devastating effects it can have, I tell people not to take chances. We have powerful weapons like vaccines to prevent those devastating outcomes.”

This was the third COVID-19 vaccine – and sixth, including boosters – taken by Nurse Lindsay, who has since been elevated to the role of vice president of public health advocacy at Northwell. The FDA approved Pfizer’s vaccine on Monday followed by the CDC’s Advisory Committee on Immunization Practices on Tuesday.

Michelle Chester, FNP-BC, DNP, senior director of Employee Health Services at Northwell, administered the shot. She also gave Nurse Lindsay the vaccine in 2020. Also joining Nurse Lindsay in receiving vaccinations were: Adam Berman, MD, associate chair of emergency medicine at Long Island Jewish Medical Center in New Hyde Park; Mozhdeh Mehrabian, a respiratory therapist at North Shore University Hospital in Manhasset; and Mangala Narasimhan, MD, senior vice president of critical care services at Northwell.

“Vaccination is and has proven to be an important tool to fight against the severity of COVID-19,” said Jill Kalman, MD, chief medical officer and deputy physician in chief at Northwell Health. “We’re here now to reinforce that there is extra protection available against the newest COVID-19 variants as the FDA and CDC have approved a new seasonal vaccine.”

Northwell has administered about 800,000 doses of COVID-19 vaccine since the end of 2020. The FDA and CDC have said the vaccine is safe and effective for anyone ages 6 months and older. Northwell Health will offer both Pfizer and Moderna vaccines to its employees and the general public through its ambulatory network.

“It’s been three-and-a-half years since COVID hit the world and we have not forgotten,” said Bruce Farber, MD, chief of public health and epidemiology at Northwell. “At the peak of the First Wave, our health system had nearly 3,500 hospitalized COVID patients. This week, it’s less than 200. Even though that number has bumped up considerable since July, the majority are incidental cases, meaning that they have been hospitalized for some other reason. Nevertheless, COVID causes at lot of morbidity and it interrupts lives. That’s why we support vaccines as a major way to prevent COVID.”

Dr. Farber also warned of a surge later this fall and into the winter – another possible “tripledemic” of COVID, flu and RSV – unless Americans embrace vaccines. Flu and COVID vaccines can be taken at the same time. RSV is also available and should be considered for at-risk populations.

Northwell Health is New York State’s largest health system and private employer.

Media Assets:
VIDEO
Press Conference + Broll: https://drive.google.com/file/d/1ksUAhBtSBgt3bnuVCV_gGoLXn8SwUfmL/view?usp=sharing

PHOTO:
https://northwellstudios.smugmug.com/2023-NON-EVENTS/September/2052250-Pfizer-COVID-VaccinePhoto-LW-91323/n-mLhNb5/

About Northwell Health

Northwell Health is New York State’s largest health care provider and private employer, with 21 hospitals, about 900 outpatient facilities and more than 12,000 affiliated physicians. We care for over two million people annually in the New York metro area and beyond, thanks to philanthropic support from our communities. Our 85,000 employees – 18,900 nurses and 4,900 employed doctors, including members of Northwell Health Physician Partners – are working to change health care for the better. We’re making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Twitter, Instagram and LinkedIn.

Contacts

Jason Molinet
516-321-6705
jmolinet@northwell.edu

Northwell Health


Release Versions

Contacts

Jason Molinet
516-321-6705
jmolinet@northwell.edu

More News From Northwell Health

Feinstein Institutes Technology That Restores Movement and Sensation After Paralysis Featured in Nature Medicine

MANHASSET, N.Y.--(BUSINESS WIRE)--Nature Medicine today featured on its cover the findings from The Feinstein Institutes for Medical Research, demonstrating that its “double neural bypass” technology can restore immediate function and promote lasting neurological recovery in complete spinal cord injury. The study reveals how the novel hybrid brain computer interface (BCI) system combines cutting-edge BCI technology with artificial intelligence (AI) and high-precision electrical stimulation of t...

Feinstein Institutes Scientists Discover How Bioelectronic Medicine Activates Blood Clotting

MANHASSET, N.Y.--(BUSINESS WIRE)--For centuries, stopping severe bleeding has relied on physical pressure or surgery. A pioneering study from Northwell Health’s Feinstein Institutes for Medical Research now demonstrates that a small, wearable device placed on the ear can activate the vagus nerve and accelerate clot formation, offering new hope against life-threatening hemorrhage.This first-in-human mechanistic study, recently published in the journal Bioelectronic Medicine – an open-access journ...

Renowned Physician-Scientist Brian S. Kim Joins Northwell as First Chief Biotechnology Officer

MANHASSET, N.Y.--(BUSINESS WIRE)--Building on its legacy as the global pioneer in bioelectronic medicine, The Feinstein Institutes for Medical Research, the research home of Northwell Health, today announced the appointment of Brian S. Kim, MD, MTR, as vice president and chief biotechnology officer at Northwell and head of intellectual asset management at the Feinstein Institutes. Dr. Kim will also serve as the inaugural Robin and Jack Ross Chair in Bioelectronic Medicine and Neuroimmunology and...
Back to Newsroom